Learn more

INST FARM

Overview
  • Total Patents
    15
  • GoodIP Patent Rank
    146,095
About

INST FARM has a total of 15 patent applications. Its first patent ever was published in 2011. It filed its patents most often in Poland and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are NOVELIX PHARMACEUTICALS INC, SCHERING AKTIENGELLSCHAFT and EURO CELTIQUE.

Patent filings in countries

World map showing INST FARMs patent filings in countries
# Country Total Patents
#1 Poland 14
#2 Canada 1

Patent filings per year

Chart showing INST FARMs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Chodyński Michał 6
#2 Cmoch Piotr 6
#3 Dams Iwona 6
#4 Krupa Małgorzata 5
#5 Kutner Andrzej 4
#6 Sidoryk Katarzyna 4
#7 Filip Katarzyna 4
#8 Michalak Olga 3
#9 Zezula Marta 3
#10 Ostaszewska Anna 3

Latest patents

Publication Filing date Title
PL416544A1 Method for producing derivative of 3,4-dihydroxyphenyllactic acid to be applied in synthesis of rosmarinic acid
PL416023A1 Method for preparation on the form of tablets containing prasugrel hydrochloride
PL413649A1 Method for obtaining dutasteride with pharmaceutical purity
PL412780A1 Method for producing genistein on technical scale
PL412198A1 New impurity in the synthesis of eplerenone and method for removing it
PL411707A1 Method for obtaining anthraquinone-1-carboxylic acids by way of their oxidation
PL411469A1 New impurity in the synthesis of olmesartan medoxomil
PL410823A1 New ethylamides of prostaglandin F<sub>2</sub><sub>α</sub> 5-trans derivatives
PL410822A1 Three-component combination to be used in the combined treatment of non-small-cell lung carcinoma
PL410824A1 Application of 2,2-bis(hydroxymethyl)propyl esters of prostenic and prostadienic acids as the original compounds in the synthesis of prostamids F<sub>2</sub><sub>α</sub>
PL399299A1 N-substituted cyclic amides of dermorfin ureido analogues and methods for their preparation
PL398389A1 Method for producing analogues of prostaglandin F2α structure 13,14-en-15-ol
PL397662A1 Combination therapy of non-small-cell lung carcinoma